FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034280065> ?p ?o ?g. }

• W2034280065 endingPage "792" @default.
• W2034280065 startingPage "786" @default.
• W2034280065 abstract "The increasing prevalence of atopic eczema has been linked to the alteration of the Western diet, namely the reduced consumption of omega-3 (n-3) polyunsaturated fatty acids (PUFA) and an increased omega-6 (n-6) PUFA intake.The aim of the pilot study was to determine the efficacy of dietary n-3 PUFA docosahexaenoic acid (DHA) in patients with atopic eczema.Fifty-three patients suffering from atopic eczema aged 18-40 years were recruited into this randomized, double-blind, controlled trial and received either DHA 5.4 g daily (n = 21) or an isoenergetic control of saturated fatty acids (n = 23) for 8 weeks. At weeks 0, 4, 8 and 20 the clinical outcome was assessed by the SCORAD (severity scoring of atopic dermatitis) index. IgE production and activation of peripheral blood mononuclear cells (PBMC) were analysed. Plasma fatty acids were measured by gas chromatography.DHA, but not the control treatment, resulted in a significant clinical improvement of atopic eczema in terms of a decreased SCORAD [DHA: baseline 37.0 (17.9-48.0), week 8 28.5 (17.6-51.0); control: baseline 35.4 (17.2-63.0), week 8 33.4 (10.7-56.2)]. A significant reduction of anti-CD40/interleukin 4-mediated IgE synthesis of PBMC was detected in the DHA group only. Supplementation led to a modulated activation status of PBMC in both groups. The DHA group showed an increase of plasma n-3 PUFA and a decrease in the n-6/n-3 PUFA ratio.Our data suggest that dietary DHA could be bioactive and might have a beneficial impact on the outcome of atopic eczema, but our results need to be confirmed in a larger study." @default.
• W2034280065 created "2016-06-24" @default.
• W2034280065 creator A5015366434 @default.
• W2034280065 creator A5040832038 @default.
• W2034280065 creator A5048797041 @default.
• W2034280065 creator A5053003825 @default.
• W2034280065 creator A5053191247 @default.
• W2034280065 creator A5059364953 @default.
• W2034280065 creator A5066708354 @default.
• W2034280065 creator A5045890495 @default.
• W2034280065 date "2008-04-01" @default.
• W2034280065 modified "2023-10-14" @default.
• W2034280065 title "Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial" @default.
• W2034280065 cites W1578779604 @default.
• W2034280065 cites W1756135215 @default.
• W2034280065 cites W1966493962 @default.
• W2034280065 cites W1983731138 @default.
• W2034280065 cites W1986654080 @default.
• W2034280065 cites W1993785588 @default.
• W2034280065 cites W2007128613 @default.
• W2034280065 cites W2030248217 @default.
• W2034280065 cites W2032137791 @default.
• W2034280065 cites W2054021671 @default.
• W2034280065 cites W2056716090 @default.
• W2034280065 cites W2057760254 @default.
• W2034280065 cites W2057782686 @default.
• W2034280065 cites W2059298404 @default.
• W2034280065 cites W2059830147 @default.
• W2034280065 cites W2064535896 @default.
• W2034280065 cites W2072474455 @default.
• W2034280065 cites W2073102792 @default.
• W2034280065 cites W2074763735 @default.
• W2034280065 cites W2099363307 @default.
• W2034280065 cites W2104808482 @default.
• W2034280065 cites W2109225320 @default.
• W2034280065 cites W2129298218 @default.
• W2034280065 cites W2138021054 @default.
• W2034280065 cites W2142066262 @default.
• W2034280065 cites W2143138262 @default.
• W2034280065 cites W2147860005 @default.
• W2034280065 cites W2151613538 @default.
• W2034280065 cites W2160859185 @default.
• W2034280065 cites W2164071126 @default.
• W2034280065 cites W2169719640 @default.
• W2034280065 cites W2211467290 @default.
• W2034280065 cites W3022993324 @default.
• W2034280065 doi "https://doi.org/10.1111/j.1365-2133.2007.08430.x" @default.
• W2034280065 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18241260" @default.
• W2034280065 hasPublicationYear "2008" @default.
• W2034280065 type Work @default.
• W2034280065 sameAs 2034280065 @default.
• W2034280065 citedByCount "76" @default.
• W2034280065 countsByYear W20342800652012 @default.
• W2034280065 countsByYear W20342800652013 @default.
• W2034280065 countsByYear W20342800652014 @default.
• W2034280065 countsByYear W20342800652015 @default.
• W2034280065 countsByYear W20342800652016 @default.
• W2034280065 countsByYear W20342800652017 @default.
• W2034280065 countsByYear W20342800652018 @default.
• W2034280065 countsByYear W20342800652019 @default.
• W2034280065 countsByYear W20342800652020 @default.
• W2034280065 countsByYear W20342800652021 @default.
• W2034280065 countsByYear W20342800652022 @default.
• W2034280065 countsByYear W20342800652023 @default.
• W2034280065 crossrefType "journal-article" @default.
• W2034280065 hasAuthorship W2034280065A5015366434 @default.
• W2034280065 hasAuthorship W2034280065A5040832038 @default.
• W2034280065 hasAuthorship W2034280065A5045890495 @default.
• W2034280065 hasAuthorship W2034280065A5048797041 @default.
• W2034280065 hasAuthorship W2034280065A5053003825 @default.
• W2034280065 hasAuthorship W2034280065A5053191247 @default.
• W2034280065 hasAuthorship W2034280065A5059364953 @default.
• W2034280065 hasAuthorship W2034280065A5066708354 @default.
• W2034280065 hasConcept C126322002 @default.
• W2034280065 hasConcept C137061746 @default.
• W2034280065 hasConcept C168563851 @default.
• W2034280065 hasConcept C19038510 @default.
• W2034280065 hasConcept C202751555 @default.
• W2034280065 hasConcept C203014093 @default.
• W2034280065 hasConcept C207480886 @default.
• W2034280065 hasConcept C2776091944 @default.
• W2034280065 hasConcept C2776173921 @default.
• W2034280065 hasConcept C2777171753 @default.
• W2034280065 hasConcept C2777697326 @default.
• W2034280065 hasConcept C2778329239 @default.
• W2034280065 hasConcept C2779134260 @default.
• W2034280065 hasConcept C2780501606 @default.
• W2034280065 hasConcept C543025807 @default.
• W2034280065 hasConcept C55493867 @default.
• W2034280065 hasConcept C71924100 @default.
• W2034280065 hasConcept C86803240 @default.
• W2034280065 hasConcept C90924648 @default.
• W2034280065 hasConceptScore W2034280065C126322002 @default.
• W2034280065 hasConceptScore W2034280065C137061746 @default.
• W2034280065 hasConceptScore W2034280065C168563851 @default.
• W2034280065 hasConceptScore W2034280065C19038510 @default.
• W2034280065 hasConceptScore W2034280065C202751555 @default.
• W2034280065 hasConceptScore W2034280065C203014093 @default.

• next